Institut Jerome Lejeune - Company Review
Institut Jerome Lejeune - Company ReviewSummary
Institut Jerome Lejeune (Jerome Lejeune) is a healthcare service provider that offers consultation services for patients suffering from genetic disorders. The institute provides consultation services for Trisomy 21 and develops improved treatment to normalize functions of mental patients. It offers treatments for diseases that include Fragile X syndrome, 5p deletion, Trisomy 21, angelman syndrome, williams-beuren syndrome, other genetic defects, and unexplained mental impairment, among others. Jerome Lejeune designs and conducts clinical research programmes directly with the patients and the families. The institute offers training, information services and various public courses for professionals. Jerome Lejeune is headquartered in Paris, France.
This comprehensive company report of Institut Jerome Lejeune provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.